Highly cytotoxic trithiophenolatodiruthenium complexes of the type [(η6-p-MeC6H4Pr i )2Ru2(SC6H4-p-X)3]+: synthesis, molecular structure, electrochemistry, cytotoxicity, and glutathione oxidation potential

被引:60
作者
Giannini, Federico [1 ]
Furrer, Julien [1 ]
Ibao, Anne-Flore [2 ]
Suess-Fink, Georg [2 ]
Therrien, Bruno [2 ]
Zava, Olivier [3 ]
Baquie, Mathurin [3 ]
Dyson, Paul J. [3 ]
Stepnicka, Petr [4 ]
机构
[1] Univ Bern, Dept Chem & Biochem, CH-3012 Bern, Switzerland
[2] Univ Neuchatel, Inst Chim, CH-2000 Neuchatel, Switzerland
[3] Ecole Polytech Fed Lausanne, Inst Sci & Ingn Chim, CH-1015 Lausanne, Switzerland
[4] Charles Univ Prague, Dept Inorgan Chem, Fac Sci, CR-12840 Prague 2, Czech Republic
来源
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY | 2012年 / 17卷 / 06期
基金
瑞士国家科学基金会;
关键词
Ruthenium; Cancer; Cytotoxicity; Lipophilicity; Glutathione oxidation; ORGANOMETALLIC ANTICANCER COMPLEXES; RUTHENIUM COMPLEXES; DNA-BINDING; AGENTS; DRUGS; RECOGNITION; MECHANISMS; ADDUCTS; DESIGN; ACIDS;
D O I
10.1007/s00775-012-0911-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A series of cationic dinuclear p-cymene ruthenium trithiophenolato complexes of the type [(eta(6)-p-MeC6H4Pr (i) )(2)Ru-2(SC6H4-p-X)(3)](+) (1 X is H, 2 X is Me, 3 X is Ph, 4 X is Br, 5 X is OH, 6 X is NO2, 7 X is OMe, 8 X is CF3, 9 X is F, 10 X is Pr (i) , 11 X is Bu (t) ) have been synthesized from the reaction of [(eta(6)-p-MeC6H4Pr (i) )RuCl2](2) with the corresponding thiol, isolated as the chloride salts, and further studied for their electrochemical properties, cytotoxicity towards human ovarian cancer cells, and catalytic activity for glutathione (GSH) oxidation. Complex 1 was also compared with the benzene and hexamethylbenzene analogues [(eta(6)-C6H6)(2)Ru-2(SC6H5)(3)](+) (12) and [(eta(6)-C6Me6)(2)Ru-2(SC6H5)(3)](+) (13). The most active compound [11]Cl was structurally studied by single-crystal X-ray diffraction analysis. The concentrations corresponding to 50 % inhibition of cancer cell growth (IC50 values) in the A2780 and A2780cisR cell lines of these complexes except for 6 were in the submicromolar range, complex 11 showing an IC50 value of 0.03 A mu M in both cell lines. The high in vitro anticancer activity of these complexes may be at least partially due to their catalytic potential for the oxidation of GSH, although there is no clear correlation between the IC50 values and the turnover frequencies at about 50 % conversion. However, the cytotoxicity is tentatively correlated to the physicochemical properties of the compounds determined by the electronic influence of the substituents X (Hammett constants sigma (p)) and the lipophilicity of the thiols p-XC6H4SH (calculated log P parameters).
引用
收藏
页码:951 / 960
页数:10
相关论文
共 41 条
[1]   Synthesis of betulin derivatives and the determination of their relative using reversed-phase thin-layer chromatography [J].
Achrem-Achremowicz, Jacek ;
Kepczynska, Elzbieta ;
Zylewski, Marek ;
Janeczko, Zbigniew .
BIOMEDICAL CHROMATOGRAPHY, 2010, 24 (03) :261-267
[2]  
Advanced Chemistry Development, 2012, ACD CHEMSKETCH VERS
[3]   [Ru(η6-p-cymene)Cl2(pta)] (pta=1,3,5-triaza-7-phosphatricyclo[3.3.1.1]decane):: a water soluble compound that exhibits pH dependent DNA binding providing selectivity for diseased cells [J].
Allardyce, CS ;
Dyson, PJ ;
Ellis, DJ ;
Heath, SL .
CHEMICAL COMMUNICATIONS, 2001, (15) :1396-1397
[4]   The hydrolysis of the anti-cancer ruthenium complex NAMI-A affects its DNA binding and antimetastatic activity: an NMR evaluation [J].
Bacac, M ;
Hotze, ACG ;
van der Schilden, K ;
Haasnoot, JG ;
Pacor, S ;
Alessio, E ;
Sava, G ;
Reedijk, J .
JOURNAL OF INORGANIC BIOCHEMISTRY, 2004, 98 (02) :402-412
[5]   (ETA-6-HEXAMETHYLBENZENE)RUTHENIUM COMPLEXES [J].
BENNETT, MA ;
HUANG, TN ;
MATHESON, TW ;
SMITH, AK .
INORGANIC SYNTHESES, 1982, 21 :74-78
[6]   Approaching tumour therapy beyond platinum drugs Status of the art and perspectives of ruthenium drug candidates [J].
Bergamo, A. ;
Gaiddon, C. ;
Schellens, J. H. M. ;
Beijnen, J. H. ;
Sava, G. .
JOURNAL OF INORGANIC BIOCHEMISTRY, 2012, 106 (01) :90-99
[7]   Organometallic Antitumour Agents with Alternative Modes of Action [J].
Casini, Angela ;
Hartinger, Christian G. ;
Nazaroy, Alexey A. ;
Dyson, Paul J. .
MEDICINAL ORGANOMETALLIC CHEMISTRY, 2010, 32 :57-80
[8]   Highly selective binding of organometallic ruthenium ethylenediamine complexes to nucleic acids: Novel recognition mechanisms [J].
Chen, HM ;
Parkinson, JA ;
Morris, RE ;
Sadler, PJ .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2003, 125 (01) :173-186
[9]   Induced-fit recognition of DNA by organometallic complexes with dynamic stereogenic centers [J].
Chen, HM ;
Parkinson, JA ;
Nováková, O ;
Bella, J ;
Wang, FY ;
Dawson, A ;
Gould, R ;
Parsons, S ;
Brabec, V ;
Sadler, PJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (25) :14623-14628
[10]  
Chérioux F, 2003, EUR J INORG CHEM, P1043